Remedium Lifecare Ltd banner
R

Remedium Lifecare Ltd
BSE:539561

Watchlist Manager
Remedium Lifecare Ltd
BSE:539561
Watchlist
Price: 0.48 INR -4% Market Closed
Market Cap: ₹423.4m

Remedium Lifecare Ltd
Cash from Financing Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Remedium Lifecare Ltd
Cash from Financing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
R
Remedium Lifecare Ltd
BSE:539561
Cash from Financing Activities
₹10.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Financing Activities
-₹13.3B
CAGR 3-Years
14%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Financing Activities
-₹14.3B
CAGR 3-Years
-16%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Financing Activities
-₹17.5B
CAGR 3-Years
-25%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Lupin Ltd
NSE:LUPIN
Cash from Financing Activities
₹14.5B
CAGR 3-Years
103%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash from Financing Activities
-₹19.1B
CAGR 3-Years
-10%
CAGR 5-Years
-6%
CAGR 10-Years
N/A
No Stocks Found

Remedium Lifecare Ltd
Glance View

Market Cap
423.4m INR
Industry
Pharmaceuticals

Remedium Lifecare Ltd is a IN-based company operating in Pharmaceuticals industry. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2016-01-12. Remedium Lifecare Limited is an India-based pharmaceutical company. The firm is aligned across two business verticals: Products and Services. The Products business comprises trading and sale of active pharmaceutical ingredients (APIs) and intermediates to innovator and generic pharmaceutical players in both domestic and international markets including the regulated markets. The company is engaged in the business of trading in advanced pharmaceutical intermediates, API's and other pharma products used, such as iso propyl alcohol, cyclohexane, di iso propyl amine, ethyl acetate, hydrazine hydrate, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride, sodium carbonate (soda ash), amino isophthalic acid, tellurium(IV) oxide, Grignard reagent, selenium metal powder and trimethyl sulfoxonium iodide (TMSI). The company is involved with the manufacture of various APIs, such as atorvastatin calcium (Amorphous) and citalopram hydrochloride.

REMLIFE Intrinsic Value
Not Available
R

See Also

What is Remedium Lifecare Ltd's Cash from Financing Activities?
Cash from Financing Activities
10.8B INR

Based on the financial report for Mar 31, 2025, Remedium Lifecare Ltd's Cash from Financing Activities amounts to 10.8B INR.

What is Remedium Lifecare Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
1 903%

Over the last year, the Cash from Financing Activities growth was 1 903%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett